Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Go back to Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio| 12% MONSANTO STRIDES DUE MARCH 26, 2010 (NASDAQ: MYX) | Delayed: 10.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.04 | 52 Week High | $29.95 | |||
| Open | $10.04 | 52 Week Low | $16.83 | |||
| Day High | $10.04 | P/E | N/A | |||
| Day Low | $10.04 | EPS | $0.00 | |||
| Volume | 13 | |||||
